ST Germain D J Co. Inc. Acquires 476 Shares of Elevance Health, Inc. (NYSE:ELV)

ST Germain D J Co. Inc. grew its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 56.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,322 shares of the company’s stock after purchasing an additional 476 shares during the period. ST Germain D J Co. Inc.’s holdings in Elevance Health were worth $488,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of ELV. Raelipskie Partnership bought a new position in Elevance Health during the third quarter worth $26,000. PSI Advisors LLC bought a new position in Elevance Health during the third quarter worth $27,000. Eastern Bank bought a new position in Elevance Health during the third quarter worth $31,000. Dunhill Financial LLC raised its stake in Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after buying an additional 26 shares during the last quarter. Finally, Peterson Financial Group Inc. bought a new position in Elevance Health during the third quarter worth $44,000. Institutional investors own 89.24% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on ELV. Raymond James set a $485.00 target price on shares of Elevance Health in a research note on Friday, October 18th. Stephens reissued an “underperform” rating on shares of Elevance Health in a research note on Friday, October 18th. Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a report on Monday, January 6th. Barclays reduced their price target on shares of Elevance Health from $622.00 to $501.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Finally, Cantor Fitzgerald reduced their price target on shares of Elevance Health from $600.00 to $485.00 and set an “overweight” rating for the company in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $536.53.

Elevance Health Stock Down 0.5 %

Shares of NYSE ELV opened at $381.41 on Friday. The stock has a market capitalization of $88.46 billion, a P/E ratio of 13.90, a P/E/G ratio of 1.15 and a beta of 0.84. The company has a 50-day moving average price of $391.39 and a 200-day moving average price of $472.20. Elevance Health, Inc. has a 1 year low of $362.21 and a 1 year high of $567.26. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50.

Elevance Health (NYSE:ELV) last released its quarterly earnings results on Thursday, October 17th. The company reported $8.37 earnings per share for the quarter, missing the consensus estimate of $9.66 by ($1.29). Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The firm had revenue of $44.72 billion for the quarter, compared to analysts’ expectations of $43.47 billion. During the same quarter last year, the firm posted $8.99 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, equities research analysts forecast that Elevance Health, Inc. will post 32.96 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 20th. Investors of record on Thursday, December 5th were issued a dividend of $1.63 per share. This represents a $6.52 annualized dividend and a yield of 1.71%. The ex-dividend date was Thursday, December 5th. Elevance Health’s dividend payout ratio (DPR) is presently 23.77%.

Insider Buying and Selling

In other Elevance Health news, EVP Charles Morgan Kendrick, Jr. sold 7,417 shares of Elevance Health stock in a transaction dated Friday, October 18th. The shares were sold at an average price of $432.14, for a total value of $3,205,182.38. Following the sale, the executive vice president now owns 8,423 shares of the company’s stock, valued at approximately $3,639,915.22. The trade was a 46.82 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.35% of the stock is owned by corporate insiders.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.